Does periolesional edema influence dose prescriptin/fractionation for SRS brain mets?
Dear colleagues, I have an 80 years old patients known to have a lung adenocarcinoma since 2017, treated with systemic treatments and one course of brain SRS in 2017 with complete remission of the lesions. he presents with two solitary brain lesions one right frontal of 4mm another right post parietal of 26 mm with intralesional hemorrhage and important peri-lesional edema (no midline shift ), inoperable do you take in consideration the perilesional edema to decide for one Shot SRS or... Does periolesional edema influence dose prescriptin/fractionation for SRS brain mets? (Source: Student Doctor Network)
Source: Student Doctor Network - April 8, 2020 Category: Universities & Medical Training Authors: Kroll2013 Tags: Radiation Oncology Source Type: forums
Re: Ischaemic stroke, haemorrhage, and mortality in older patients with chronic kidney disease newly started on anticoagulation for atrial fibrillation: a population based study from UK primary care
(Source: BMJ Comments)
Source: BMJ Comments - March 6, 2018 Category: General Medicine Source Type: forums
Two Doctors Meet - Annals of Int. Med
A teachable moment.... Two Doctors Meet The doctor walked out of one of his clinic rooms and told his nurse he thought he was having a stroke. By the time I saw him, he was nonverbal, globally aphasic, unable to move his right side, his brain filling with rapidly expanding hemorrhage. He didn't understand what I was asking him to do. He couldn't tell me what he was feeling, but he recognized my white coat. He recognized the tone in my voice. He recognized the expression on my... Two Doctors Meet - Annals of Int. Med (Source: Student Doctor Network)
Source: Student Doctor Network - January 17, 2018 Category: Universities & Medical Training Authors: arcus Source Type: forums
BP in brain stims?
So we do a lot of brain stims for Parkinson's. And the surgeon requires a blood pressure of sbp
Source: Student Doctor Network - April 15, 2017 Category: Universities & Medical Training Authors: waterbottle10 Source Type: forums
FDA Investigation Finds No Excess Bleeding Risk for Dabigatran
In its latest assessment of a highly controversial issue, the FDA has found no indication that bleeding rates for dabigatran (Pradaxa, Boehringer-Ingelheim) are any higher than the bleeding rates for warfarin. The FDA investigation was in response to the large number of post-marketing reports of bleeding in people taking dabigatran. Click here to for the full FDA statement. Here is the first paragraph of the statement: The U.S. Food and Drug Administration (FDA) has evaluated new information about the risk of serious bleeding associated with use of the anticoagulants (blood thinners) dabigatran (Pradaxa) and warf...
Source: CardiologyNetwork.com - October 13, 2013 Category: Cardiology Authors: Indian Diabetics Foundation Team Source Type: forums